ישראל - עברית - Ministry of Health

novartis israel ltd - capmatinib as dihydrochloride monohydrate - טבליות מצופות פילם - capmatinib as dihydrochloride monohydrate 150 mg - capmatinib

ישראל - עברית - Ministry of Health

novartis israel ltd - capmatinib as dihydrochloride monohydrate - טבליות מצופות פילם - capmatinib as dihydrochloride monohydrate 200 mg - capmatinib

ישראל - עברית - Ministry of Health

padagis israel agencies ltd, israel - melphalan - טבליה - melphalan 2 mg - melphalan - melphalan - for the palliative treatment of multiple myeloma and of non-epithelial carcinoma of the ovary.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 100 mg - olaparib

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 100 mg - olaparib

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 150 mg - olaparib

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - olaparib - טבליות מצופות פילם - olaparib 150 mg - olaparib

ישראל - עברית - Ministry of Health

merck serono ltd - tepotinib as hydrochloride hydrate - טבליות מצופות פילם - tepotinib as hydrochloride hydrate 225 mg - tepotinib

ישראל - עברית - Ministry of Health

perrigo israel agencies ltd - melphalan - אבקה וממס להכנת תמיסה להזרקה - melphalan 50 mg/vial - melphalan - melphalan - for the palliative treatment of multiple myeloma and for the palliation of non resectable epithelial cancer of the ovary.

ישראל - עברית - Ministry of Health

pharmalogic ltd - gemcitabine as hydrochloride 200 mg - lyophilized powder for injection - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.